+ +

•  

   

     Gel: 8%SDS-PAGE, Lysate: 80 μg, Lane: 293T cell, Primary antibody: P01886(THAP4 Antibody) at dilution 1/250, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 10 seconds    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human lung cancer tissue using P01886(THAP4 Antibody) at dilution 1/30. (Original magnification: ×200)    

  
  

The THAP4 antibody is a tool used to detect THAP4 (THAP domain-containing protein 4), a member of the THAP family of proteins characterized by a conserved N-terminal THAP domain, a zinc-coordinating motif involved in DNA binding. THAP4 is encoded by the *THAP4* gene in humans and is implicated in transcriptional regulation, chromatin remodeling, and cellular processes such as proliferation and apoptosis. Though less studied than other THAP proteins (e.g., THAP1 or THAP9), THAP4 is suggested to function as a transcription factor or epigenetic modulator, potentially interacting with protein complexes to regulate gene expression. Its biological roles remain under investigation, with possible links to cancer, neurodevelopment, and metabolic pathways.

THAP4 antibodies are primarily utilized in research to study protein expression, localization, and interactions via techniques like Western blotting, immunohistochemistry, and immunofluorescence. These antibodies are critical for validating THAP4 expression in cell lines or tissues, assessing its role in disease models, or exploring its molecular mechanisms. Commercial THAP4 antibodies are typically raised against specific epitopes, often in rabbits or mice, and require validation for specificity and sensitivity. Researchers should verify antibody performance using knockout controls or siRNA-mediated knockdown to minimize off-target signals. Current challenges include limited data on THAP4’s precise physiological functions and a scarcity of standardized reagents, highlighting the need for further studies to elucidate its contributions to health and disease.